Table 2.
Effects of MPHE, hesperidin, and quercetin on serum total bilirubin and albumin levels and LDH activity of NAPAP-administrated rats.
| Groups | Parameter | |||||
|---|---|---|---|---|---|---|
| LDH (U/L) | % change | Total bilirubin (mg/dl) | % change | Albumin (g/dl) | % change | |
| Normal | 1776 ± 42.56 | 0.70 ± 0.04 | 3.23 ± 0.08 | |||
| NAPAP | 3522 ± 98.20a | 98.31 | 1.31 ± 0.12a | 87.14 | 2.71 ± 0.07a | -16.09 |
| NAPAP+MPHE | 1593 ± 75.98b | -54.77 | 0.63 ± 0.01b | -51.90 | 3.13 ± 0.06b | 15.49 |
| NAPAP+hesperidin | 1691 ± 69.45b | -51.98 | 0.61 ± 0.01b | -53.43 | 3.19 ± 0.07b | 17.71 |
| NAPAP+quercetin | 1699 ± 71.56b | -51.96 | 0.67 ± 0.008b | -48.85 | 3.23 ± 0.12b | 19.18 |
Data are expressed as mean ± SEM. The number of animals in each group is 6. aSignificant at P < 0.05 in comparison with the normal values. bSignificant at P < 0.05 in comparison with NAPAP values. Percentage changes are calculated by comparing NAPAP-administered control with normal control and NAPAP-administered treated rats with NAPAP-administered control.